Page 5 - Pharmaceuticals

Lupin receives CDSCO's approval for anti-allergic drug bepotastine

According to IMS, the market for plain antihistamines in India is estimated at about Rs 860 crs

Vivimed Labs & Strides Shasun to form two JVs to tap US generic market

While JV in India will own US FDA-approved plant in Alathur, Singaporean JV will own certain ANDAs

Germany's Merck & Stelis Biopharma open bioprocess scale-up lab in India

Lab, based at Bengaluru, provides end-to-end solutions from bioprocess development to manufacturing

Govt tenders may opt for local medical devices

At present, 70% of medical devices are imported in India

US Court rules in favour of Zydus in ulcerative colitis drug patent case

It ruled that Zydus' generic version of Lialda (mesalamine) does not infringe patent of Shire

Natco launches blood cancer drug pomalidomide in India

Pomalidomide is sold by Celgene Inc in the US, under the brand name Pomalyst

Torrent Pharma buys two gynaecology products from Swiss firm Novartis AG

Acquisition of Regestrone & Pregachieve brands to further fortify Torrent Pharma's hormone segment

Natco Pharma launches hepatitis C drug Velpanat in India

Velpanat is generic version of Epclusa, which contains sofosbuvir (400 mg) & velpatasvir (100 mg)

Japan's Otsuka Pharmaceutical buys out Claris' 20% stake in JV for $ 20 mn

With this, Otsuka to strengthen its basic IV solution and clinical nutrition business in India

Avantor acquires lab equipment & chemicals supplier VWR for $ 6.4 billion

Deal to create a major global player providing supply chain solutions for life sciences industry

US FDA renews approval for Strides Shasun's Puducherry APIs plant

With this, its last four US FDA inspections were successfully completed without any observations

Zydus Cadila receives US FDA approval for anti-inflammatory drug budesonide

Budesonide is estimated to have annual sales of $ 285.8 million, according to IMS

Jubilant to acquire radiopharmacy business of US-based Triad Isotopes

Triad operates the second largest radiopharmacy network in the US with more than 50 pharmacies

Daiichi Sankyo plans $133 mn investment to strengthen biopharma facilities

It will invest in three Japanese facilities to support growth of antibody drug conjugate portfolio

Dr Reddy's Laboratories launches cholesterol lowering drug in US

The drug is the generic version of MSD International's Vytorin (ezetimibe & simvastatin) tablet

Zydus Cadila receives US FDA approval for cholestyramine suspension

It is indicated as an adjunctive therapy for reduction of elevated serum cholesterol in patients

Alembic Pharmaceuticals receives US FDA nod for hypertension drugs

The approved drugs are generic versions of Daiichi Sankyo's Benicar and Benicar HCT tablets

Fujifilm expands biopharma facilities in US & UK with $ 130 mn investment

The company's new process development facilities to support growing market of biopharmaceuticals

Unichem receives US FDA nod for pain killer piroxicam capsule

It will commercialise the product from its Goa plant & source API from its API plant in Roha

Regenerative Medical Services receives DCGI nod for cell therapy product

Chondron ACI is indicated for use of articular cartilage defects of knee, ankle & shoulder joints